GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) NSE

2,480.00

-20.1999(-0.81%)

Updated at December 24 03:30PM

Currency In INR

Valuation

Market Cap473.89B
Enterprise Value468.6B
P/E Ratio44.1
PEG Ratio85.32
Price/Sales Ratio11.36
Price/Book Ratio24.67
Enterprise/Revenue11.17
Enterprise/EBITDA33.6

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.26
Operating Margin0.4

Management Effectiveness

Return On Assets0.26
Return On Equity0.52

Income Statement

Revenue37.49B
Revenue/Share218.94
Gross Profit23.35B
EBITDA11.53B
Net Income9.28B
Diluted EPS54.76

Balance Sheet

Total Cash20.61B
Total Cash/Share121.66
Total Debt357.1M
Total Debt/Equity0.02
Current Ratio1.78
Book Value Per Share100.81

Price History

52-Week Change9.82
52-Week High3,515.7
52-Week Low1,921
Moving Average 50 Days2,586.28
Moving Average 200 Days2,856.76

Statistics

Average Volume82,096
Shares Outstanding169.41M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate54
Trailing Annual Dividend Yield2.17
Payout Ratio0
Last Split Factor2:1
Last Split DateSeptember 11, 2018